Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : La Jolla Diagnostics, Inc.(OTC BB: LAJD) -- Ignore unavailable to you. Want to Upgrade?

To: Egolpi who wrote (21)	5/28/1998 3:52:00 PM
From: jeffrey rainey	Read Replies (1) \| Respond to of 168

La Jolla Diagnostics, Inc. Enhances Heat Stability of its Feverfew Products PR Newswire - May 28, 1998 13:21 LAJD %MTC %PDT V%PRN P%PRN LA JOLLA, Calif., May 28 /PRNewswire/ -- La Jolla Diagnostics, Inc. (OTC Bulletin Board: LAJD), announced today that it has developed a process that enhances the heat stability of its solutions which contain the herb feverfew. Feverfew is the common name for Tanacetum Parthenium, a flowering plant related to the chrysanthemum, whose leaves have been used for centuries in herbal remedies for the treatment of various conditions including migraine headaches. It is traditionally recommended that feverfew be kept in a cool environment or refrigerated when stored for a long period of time. This new process should enhance the Company's ability to distribute and market its feverfew products. It may also have broad ramifications on other products the Company is developing. La Jolla Diagnostics is a company engaged in the development and marketing of diagnostic tests and consumer health care products, and the licensing of drug delivery systems. SOURCE La Jolla Diagnostics, Inc. /CONTACT: Clenton Alexander of La Jolla Diagnostics, Inc., 800-454-6790, Fax: 619-454-7851/ /Web site: lajd.com (LAJ